Update On Shelhigh/US Agreement

Food Insecurity and the Dangers of Infant Formula Dilution

In the study through 76 weeks, no new risks were observed with once-daily upadacitinib (15 mg or 30 mg).

January 30th 2023

Saol Therapeutics submits NDA for SL1009 to treat Pyruvate Dehydrogenase Complex Deficiency

Demystifying Infant Formula

If approved, SL1009 has the potential to be the first approved medication for PDCD, and would be available as an oral solution.

October 11th 2022

Healthy eyes in a digital world

Image credit: © maxsim - stock.adobe.com

Colleen Sloan, PA-C, RDN

Navigating the holiday health paradox

Colleen Sloan, PA-C, RDN, details how technology can affect eye health in children and identifies which nutrients can help mitigate its effect.

Image credit:© fahrwasser - stock.adobe.com

Mike Hennessy Jr, President and CEO

Upadacitinib effective in treating atopic dermatitis through 76 weeks

Mike Hennessy Jr. shares his thoughts on the holiday health paradox.

Related Content

Food Insecurity and the Dangers of Infant Formula Dilution

In the study through 76 weeks, no new risks were observed with once-daily upadacitinib (15 mg or 30 mg).

January 30th 2023

Saol Therapeutics submits NDA for SL1009 to treat Pyruvate Dehydrogenase Complex Deficiency

Demystifying Infant Formula

If approved, SL1009 has the potential to be the first approved medication for PDCD, and would be available as an oral solution.

October 11th 2022

Healthy eyes in a digital world

Colleen Sloan, PA-C, RDN

Navigating the holiday health paradox

Colleen Sloan, PA-C, RDN, details how technology can affect eye health in children and identifies which nutrients can help mitigate its effect.

Mike Hennessy Jr, President and CEO